Xenon Pharmaceuticals (XENE) PT Lowered to $90 at Jefferies

September 28, 2026 5:08 AM

Jefferies analyst Andrew Tsai lowered the price target on Xenon Pharmaceuticals (NASDAQ: XENE) to $90.00 (from $100.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found